Jeff Johnson
Stock Analyst at Baird
(4.67)
# 205
Out of 4,413 analysts
77
Total ratings
56.25%
Success rate
38.74%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $367 → $378 | $336.50 | +12.33% | 5 | May 1, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $333 → $370 | $282.38 | +31.03% | 11 | Apr 25, 2024 | |
| ALC Alcon | Reiterates: Outperform | $94 | $77.58 | +21.17% | 5 | Jan 30, 2024 | |
| PODD Insulet | Upgrades: Outperform | $180 → $238 | $171.94 | +38.42% | 8 | Dec 21, 2023 | |
| COO The Cooper Companies | Maintains: Outperform | $100 → $103 | $89.06 | +15.09% | 13 | Aug 31, 2023 | |
| DXCM DexCom | Maintains: Outperform | $153 → $130 | $127.39 | +2.05% | 5 | Aug 21, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $33 → $32 | $36.69 | -12.78% | 5 | Aug 21, 2023 | |
| ENOV Enovis | Maintains: Outperform | $67 → $70 | $55.23 | +26.74% | 2 | Aug 4, 2023 | |
| INMD InMode | Maintains: Outperform | $53 → $61 | $17.19 | +254.86% | 2 | Jul 28, 2023 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Outperform | $172 | $120.28 | +43.00% | 9 | Jun 28, 2023 | |
| NVST Envista Holdings | Maintains: Neutral | $38 → $43 | $19.68 | +118.50% | 2 | Feb 9, 2023 | |
| HSIC Henry Schein | Downgrades: Neutral | $103 → $88 | $69.28 | +27.02% | 4 | Jun 14, 2022 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $78 → $67 | $30.01 | +123.26% | 5 | Feb 18, 2022 | |
| PDCO Patterson Companies | Upgrades: Outperform | n/a | $25.47 | - | 1 | Jan 3, 2017 |
Stryker
May 1, 2024
Maintains: Outperform
Price Target: $367 → $378
Current: $336.50
Upside: +12.33%
Align Technology
Apr 25, 2024
Maintains: Outperform
Price Target: $333 → $370
Current: $282.38
Upside: +31.03%
Alcon
Jan 30, 2024
Reiterates: Outperform
Price Target: $94
Current: $77.58
Upside: +21.17%
Insulet
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $171.94
Upside: +38.42%
The Cooper Companies
Aug 31, 2023
Maintains: Outperform
Price Target: $100 → $103
Current: $89.06
Upside: +15.09%
DexCom
Aug 21, 2023
Maintains: Outperform
Price Target: $153 → $130
Current: $127.39
Upside: +2.05%
Tandem Diabetes Care
Aug 21, 2023
Maintains: Neutral
Price Target: $33 → $32
Current: $36.69
Upside: -12.78%
Enovis
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $55.23
Upside: +26.74%
InMode
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $17.19
Upside: +254.86%
Zimmer Biomet Holdings
Jun 28, 2023
Reiterates: Outperform
Price Target: $172
Current: $120.28
Upside: +43.00%
Envista Holdings
Feb 9, 2023
Maintains: Neutral
Price Target: $38 → $43
Current: $19.68
Upside: +118.50%
Henry Schein
Jun 14, 2022
Downgrades: Neutral
Price Target: $103 → $88
Current: $69.28
Upside: +27.02%
DENTSPLY SIRONA
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $30.01
Upside: +123.26%
Patterson Companies
Jan 3, 2017
Upgrades: Outperform
Price Target: n/a
Current: $25.47
Upside: -